Medicine and Dentistry
Parkinson's Disease
100%
Diseases
27%
Wearable Sensor
24%
Medical Device
19%
Personalized Medicine
17%
COVID-19
16%
Progressive Supranuclear Palsy
16%
Geriatrics
15%
Comorbidity
12%
Timed Up and Go Test
12%
Neurodegenerative Disorder
11%
Atypical Parkinsonism
11%
Walk Test
9%
Gut Microbiome
9%
Mild Cognitive Impairment
9%
Infection
9%
Parkinsonism
9%
Physiotherapy
9%
Randomized Controlled Trial
9%
microRNA
9%
Cardiovascular System
9%
Therapeutic Drug Monitoring
9%
Lifestyle Intervention
9%
Degenerative Disease
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Prospective Study
9%
Cardiotoxicity
9%
Geriatric Assessment
9%
Observational Study
9%
Biomedical Research
9%
Functional Disease
9%
Metabolomics
9%
Cardiac Muscle Cell
9%
Pluripotent Stem Cell
9%
Congestive Heart Failure
9%
Medicine
9%
Deterioration
9%
Quality of Life
6%
Unified Parkinson's Disease Rating Scale
6%
Human Embryonic Stem Cell
6%
Frailty
5%
Motor Performance
5%
Delirium
5%
Geriatric Syndrome
5%
Immune System
5%
Disease
5%
Cardiovascular Disease
5%
Motor Activity
5%
Clinician
5%
Stereotypic Movement Disorder
5%
Keyphrases
Parkinson
19%
Parkinson's Disease
13%
GBA1
12%
Human State
9%
Human Cardiomyocytes
9%
Bioanalytics
9%
Cardiotoxicity Screening
9%
Respiratory Measurement
9%
Incubator
9%
Medicines Optimisation
9%
Comprehensive Geriatric Assessment
9%
Toxicology Research
9%
Safety Testing
9%
Levodopa-induced Dyskinesia
9%
Fall Risk Prediction
9%
Self-protection
9%
Disease Potential
9%
4th Edition
9%
Cardiovascular History
9%
Prognostic Analysis
9%
Self-defined
9%
Smartphone-based
9%
Risk Variant
9%
Xanthine
9%
Digital Therapeutics
9%
Supporting Patients
9%
Intra-household Bargaining
9%
Family Policy
9%
Risk Disclosure
9%
Standard Motion
9%
European Health Data Space
9%
Personal Health Data
9%
Disease Pathways
9%
Health Degradation
9%
Disease Duration
9%
Stair Ambulation
9%
COVID-19 Immunity
9%
Risk Aversion
9%
Dopaminergic Pathway
9%
Long-read Sequencing
9%
Luxembourgish
9%
Geriatric Wards
9%
Medical Practitioners
9%
Medical Health
9%
Nationwide Program
9%
Device Data
9%
Dementia Prevention
9%
Digital Medical Devices
9%
Major Risk Factors
9%
Diversity Inclusion
9%
Decision-making Power
6%
Data Silos
6%
Bioelectronic Medicine
6%
Centralized Data
6%
Period Prevalence
6%
Multidomain Lifestyle Intervention
6%